Journal of Diagnostics Concepts & Practice >
Factors related to enlarged perivascular spaces and lacunes in patients with hypertension
Received date: 2021-05-10
Online published: 2022-06-28
Objective: To explore the related factors of enlarged perivascular spaces (EPVS) and lacunes in the patients with hypertension, and to provide a basis for the prevention and treatment of cerebral small vessel disease. Methods: A total of 1 070 patients with essential hypertension without stroke history were enrolled, and the data was analyzed retrospectively. All patients received MRI scanning and ambulatory blood pressure monitoring. According to MRI images, they were divided into normal control, EPVS and lacunes groups, respectively. Univariate and multivariate logistic regression were performed among three groups to determine the factors related to EPVS and lacunes. Results: The indexes including age, gender, smoking, diabetes history, antiplatelet drugs, statins, hypertension duration, nocturnal blood pressure dip degree, mean systolic blood pressure, cholesterol, triglyceride, high-density lipoprotein, low density lipoprotein, urea nitrogen, creatinine, homocysteine and carotid plaque were significantly different among EPVS, lacunes and controls groups. Mean high systolic blood pressure and age were independent risk factors for EPVS, while the dipping degree of blood pressure, antiplatelet medicines and statins were independent protective factors for it. High mean systolic blood pressure, old age, smoking, and diabetes were independent risk factors for lacunes, while the dipping degree of nocturnal blood pressure, antiplatelet medicines and statins were independent protective factors for lacunes. Conclusions: For the patients with hypertension, the increase of mean systolic blood pressure and the decrease of nocturnal blood pressure dipping are the risk factors for EPVS and lacunes. Besides controlling mean systolic blood pressure level, the patients with hypertension should also receive chronotherapy to restore the normal nocturnal blood pressure dipping through changing the time of taking medicine.
YANG Yang, WU Qinmi, FENG Yulan, ZHANG Bei, FU Yi . Factors related to enlarged perivascular spaces and lacunes in patients with hypertension[J]. Journal of Diagnostics Concepts & Practice, 2021 , 20(04) : 372 -377 . DOI: 10.16150/j.1671-2870.2021.04.008
[1] | Li Q, Yang Y, Reis C, et al. Cerebral Small Vessel Di-sease[J]. Cell Transplant, 2018,27(12):1711-1722. |
[2] | Zhu H, Li Z, Lv J, et al. Effects of cerebral small vessel disease on the outcome of patients with ischemic stroke caused by large artery atherosclerosis[J]. Neurol Res, 2018,40(5):381-390. |
[3] | Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: a clinical review[J]. Neurology, 2019,92(24):1146-1156. |
[4] | Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications[J]. Lancet Neurol, 2019,18(7):684-696. |
[5] | Silvani A. Sleep disorders, nocturnal blood pressure, and cardiovascular risk: a translational perspective[J]. Auton Neurosci, 2019,218:31-42. |
[6] | Bowles NP, Thosar SS, Herzig MX, et al. Chronotherapy for hypertension[J]. Curr Hypertens Rep, 2018,20(11):97. |
[7] | Eriksson MI, Gordin D, Shams S, et al. Nocturnal Blood Pressure Is Associated With Cerebral Small-Vessel Disease in Type 1 Diabetes[J]. Diabetes Care, 2020,43(8):e96-e98. |
[8] | Zhang H, Cui Y, Zhao Y, et al. Association of circadian rhythm of blood pressure and cerebral small vessel di-sease in community-based elderly population[J]. J Gerontol A Biol Sci Med Sci, 2019,74(8):1322-1330. |
[9] | Regenhardt RW, Das AS, Lo EH, et al. Advances in understanding the pathophysiology of lacunar stroke: a review[J]. JAMA Neurol, 2018,75(10):1273-1281. |
[10] | Wardlaw JM, Benveniste H, Nedergaard M, et al. Perivascular spaces in the brain: anatomy, physiology and pathology[J]. Nat Rev Neurol, 2020,fy16(3):137-153. |
[11] | Francis F, Ballerini L, Wardlaw JM. Perivascular spaces and their associations with risk factors, clinical disorders and neuroimaging features: a systematic review and meta-analysis[J]. Int J Stroke, 2019,14(4):359-371. |
[12] | Javierre-Petit C, Schneider JA, Kapasi A, et al. Neuropathologic and cognitive correlates of enlarged perivascular spaces in a community-based cohort of older adults[J]. Stroke, 2020,51(9):2825-2833. |
[13] | Zhu YC, Tzourio C, Soumaré A, et al. Severity of dilated virchow-robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study[J]. Stroke, 2010,41(11):2483-2490. |
[14] | Guo Y, Li Y, Liu X, et al. Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age[J]. BMC Geriatr, 2020,20(1):292. |
[15] | Caplan LR. Lacunar infarction and small vessel disease: pathology and pathophysiology[J]. J Stroke, 2015,17(1):2-6. |
[16] | Del Brutto OH, Mera RM, Gillman J, et al. Calcifications in the carotid siphon correlate with silent cerebral small vessel disease in community-dwelling older adults: a population-based study in rural Ecuador[J]. Geriatr Gerontol Int, 2016,16(9):1063-1067. |
[17] | Song TJ, Kim YD, Yoo J, et al. Association between aortic atheroma and cerebral small vessel disease in patients with ischemic stroke[J]. J Stroke, 2016,18(3):312-320. |
[18] | Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review[J]. Lancet Neurol, 2007,6(7):611-619. |
[19] | Kloppenborg RP, Nederkoorn PJ, Grool AM, et al. Do lacunar infarcts have different aetiologies? Risk factor profiles of lacunar infarcts in deep white matter and basal ganglia: the second manifestations of ARTerial disease-magnetic resonance study[J]. Cerebrovasc Dis, 2017,43(3-4):161-168. |
[20] | Rutten-Jacobs LCA, Markus HS, UK young lacunar stroke DNA study. Vascular risk factor profiles differ between magnetic resonance imaging-defined subtypes of younger-onset lacunar stroke[J]. Stroke, 2017,48(9):2405-2411. |
[21] | Smith EE, Saposnik G, Biessels GJ, et al. Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2017,48(2):e44-e71. |
[22] | Wardlaw JM, Doubal F, Armitage P, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction[J]. Ann Neurol, 2009,65(2):194-202. |
[23] | Meissner A. Hypertension and the brain: a risk factor for more than heart disease[J]. Cerebrovasc Dis, 2016,42(3-4):255-262. |
/
〈 |
|
〉 |